How to Compete as a New Entrant in the DTC Obesity Market #Obesity #DTC #Healthcare
🎧 How Shotsy Grew to 350,000 Monthly Active GLP-1 Users, Ep. 9 with Aja Beckett #HealthTech #Startups #Biotech
🎧 Can AI Stop GLP-1 Patients From Churning? Ep.8 with Dr. Paul Sacher #HealthTech #AI #Pharma
🎧 Genetics Could Decide Who Wins the GLP-1 Market, Ep. 7 with 23andMe's Dr. Adam Auton #GLP1 #Genetics #HealthTech
🎧 Can Peptides Become a Real DTC Business? Ep.6 with Tim Gutwald #HealthTech #Biotech #Business
🎧 GLP-1s Are Coming for the Snack Aisle, Ep. 5 with Henry Dimbleby #Health #Business #Food
What happens when GLP-1s go off-patent? #Health #Pharma #Innovation
🎧 Can GLP-1s Save the NHS? Ep. 4 with Lord James Bethell #Health #Investment #Pharma
India is not the opportunity you think it is #Business #Investing #EmergingMarkets
🎧 Should GLP-1s be sold over the counter? Ep 3, with Dr. Beverly Tchang, MD #Health #Pharma #Investment
🎧 What investors get wrong about Hims & Hers, Ep. 2 with Paul Cerro #HealthTech #Investing #Pharma
🎧 The GLP-1 business model problem, Ep. 1 with Prof. Alex Miras #HealthTech #Pharma #Business
GLP-1s go to the Super Bowl #Health #Pharma #Business
Consumer health apps are dead #HealthTech #DigitalHealth #Startups
The 5 most important ideas for 2026 #Future #Innovation #Business
Is Your Telehealth Platform Scaring Patients Away? #HealthTech #Telehealth #DigitalHealth
When Science Fails, and Startups Fly #HealthTech #Biotech #Startups
Trump's announcement shifts competition in the GLP-1 market #Health #Pharma #Business
Why Can't Anyone Stop Compounded GLP-1s? #Health #Science #Business
What Comes After the GLP-1 Hype? #Health #Science #Business